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Purpose: The aim of the present study was to investigate the effect of chitosan molecular weight on 
size, size distribution, release rate, mucoadhesive properties and electrostatic bonding of 
alginate/chitosan microparticles containing prednisolone 
Methods: Three mucoadhesive alginate/chitosan microparticle formulations, f1, f2 and f3, were 
prepared using low, medium and high chitosan molecular weight (MW) chitosan, respectively, by directly 
spraying alginate solution into a solution of chitosan and calcium chloride at optimum conditions.  
Prednisolone was incorporated in the alginate solution prior to spraying.  The microparticles were then 
evaluated for prednisolone content, size, release rate, and mucoadhesive properties using appropriate 
methods. The formation of electrostatic and hydrogen bonds between chitosan and alginate was 
assessed by differential scanning calorimetetry (DSC) and Fourier transform infrared (FTIR). 
Results: The results indicate that high MW chitosan microparticles were significantly (p<0.05) smaller 
and more uniform in size, with better mucoadhesive properties and lower release rate than the other 
formulations.  FTIR and DSC studies indicate that stronger hydrogen and electrostatic bonding in the 
formulation containing high MW chitosan than  inthe other formulations 
Conclusion:  The physicochemical properties of chitosan-alginate microparticles are dependent on the 
molecular weight of chitosan 
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Chitosan is a biodegradable and non-toxic 
hydrophilic polysaccharide with excellent 
mucoadhesive and permeation enhancing 
properties. During the last few years, this 
polymer has been studied and used with the 
intention of providing microcapsules with a 
modified drug release profile
1,2
. Alginate is the 
name given to a family of linear 
polysaccharides found in brown algae and is 
composed of guluronic (G) and manuronic (M) 
units. Calcium alginate beads are produced by 
inotropic gelation of alginate in the presence 
of calcium ions. 
 
There has been increasing interest in the 
study of alginate-chitosan microparticles as 
carriers for controlled release of proteins and 
drugs due its biocompatible, biodegradable 
and mucoadhesive properties. A study on the 
binding of chitosan to alginate beads using 
radioactive labeled chitosan showed that 
binding between the two polymers was 
markedly increased by reducing the average 
molecular weight of chitosan and increasing 
the porosity of the alginate gel
1
. The stability 
of alginate-chitosan capsules was shown to 
depend strongly on the amount of chitosan 
bound to the capsules
2
.  The effect of various 
factors on protein release from alginate-
chitosan coacervate microcapsules including 
alginate, chitosan and calcium chloride 
concentration, loading rate, chitosan 
molecular mass and pH of gelation medium 
was investigated by Vandemberg et al
3
. In 
their study, the size and gelation time of 
microcapsules were altered to determine their 
effects on protein retention. A negatively 
charged surfactant, sodium dioctylsul-
fosuccinate, was used to prepare 
microcapsules by ionic interaction with 
chitosan
4
. The effect of deposition 
temperature on the release rate of 
indomethacin from chitosan-alginate 
microcapsules showed that the release rate 
was significantly reduced by increasing 
deposition temperature from 20 to 60 ºC
5
. 
Chitosan microspheres have also been used 
to improve release the behavior of insulin
6
. 
Hollow chitosan-alginate multilayer micro-
capsules were used as a drug delivery vehicle 
and the results showed that the encapsulated 
doxorubicin had higher efficacy than the free 
drug in terms of tumor inhibition
7
.  Drug-
loaded biodegradable microcapsules to 
control the release rate of ibuprofen fabricated 
from chitosan and sodium alginate 
demonstrate that the this system was an 





The production of microcapsules having a 
complex coacervate alginate–chitosan 
membrane and a solid alginate core vary with 
respect to the applied processes and 
materials.  There are, however, two principally 
different procedures:  
 
a) There is the one-stage procedure in which 
a complex coacervate membrane is 
formed at the interface between alginate 
and chitosan solutions when the alginate 
solution is dropped directly into chitosan 
solution
9
. This method yields capsules 
with a complex alginate–chitosan 
membrane surrounding a liquid alginate 
core. The core is subsequently gelled 
either by prior incorporation of calcium 
chloride in the chitosan solution or by 
treating the liquid core capsules with 
calcium chloride after the membrane has 
been formed.  
b) There is also a two-stage procedure in 
which the formation of calcium alginate 
beads is followed by a membrane forming 
stage where the microparticles are 
suspended in a solution of the polycation. 
In the latter case, the microparticles are 
often washed with a calcium-free solution 
to remove excess calcium ions before 




The purpose of the present study was to 
examine the influence of chitosan molecular 
weight on the properties of microparticles with 
an alginate core and chitosan coating and 
containing prednisolone as an insoluble model 
drug. This work also focuses on the in vitro 
evaluation of the mucoadhesive properties of 
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Low, medium and high molecular weight 
chitosan, micronized prednisolone, and 
calcium chloride were purchased from Fluka 
AG (Switzerland). Low viscosity sodium 
alginate (viscosity: 250 cps, 2% w/v) was 
purchased from Sigma–Aldrich Inc. (St. Louis, 
MO, USA). Other ingredients were of 
analytical grade, and used as received. 
 
Preparation of microparticles 
 
Alginate-chitosan microparticles were 
prepared by complex coacervation using 
sodium alginate as a gel core. All alginate 
solutions (2%, w/v) were prepared by 
dissolving sodium alginate in de-ionized 
water. Micronized prednisolone powder (2–
4%w/v) was then suspended thoroughly in the 
alginate solutions by vigorous stirring for 10 
min. The two procedures described earlier 
(see ‘Introduction’) were used
9
. In the one-
step method, the alginate-prednisolone 
mixture was directly sprayed into the calcium 
chloride solution (0.5–1.0%, w/v) containing 
chitosan (0.5–1.5% w/v). In the two-step 
method, the alginate-prednisolone mixture 
was sprayed into calcium chloride solution 
(0.5–1.0%w/v), followed by a membrane 
forming step where the prednisolone 
containing calcium alginate particles were 
suspended in chitosan solution (0.5–
1.5%w/v). The microparticles were allowed to 
harden for at 2 h before washing them twice 
with distilled water and dried at room 
temperature and the alginate-prednisolone 
mixture was sprayed into the gelling solutions 
using two types of spray equipment: Casals 
17500 Ripoll (Spain) and Inter Eko 1.5 lit, 
Pmax, 3 bar and rate, 0.61/min (Czech 
Republic) were used. The latter was used in 
the one-step method.   
 
Three different molecular weights of chitosan 
(low, medium, and high) were used to 
fabricate three microcapsule formulations - f1, 
f2, and f3, respectively.  These microparticles 
were then evaluated to determine the effect of 
molecular weight on microparticle properties. 
 
Determination of prednisolone content 
 
The prednisolone content was determined by 
first dispersing 100 mg of microparticles in 
distilled water under sonication Citizen SW 
1500 for at least 1 hr. The dispersion were 
filtered and the supernatant analyzed 
spectrophotometrically (Genesys 2, USA) at 
242 nm. The results are expressed as percent 
entrapment (Table 1). 
 
Particle size determination 
 
Measurements of the particle size distributions 
and mean diameters of the microparticles 
were carried out with an optical microscope 
(Nikon E 400 Japan). The overall diameters of 
at least 300 circular microparticles and/or the 
mean of two Martin diameters of noncircular 
microparticles were recorded. Geometric 
mean diameter and geometric standard 
deviation were calculated by plotting 
microparticle size against cumulative % 
undersize using logarithmic and probability 
scales, respectively. 
 
In vitro release studies 
 
Drug release profiles of prednisolone 
containing alginate-chitosan microparticles 
were determined using USP dissolution 
apparatus II (Erweka, Germany). An 
accurately weighed amount (approx. 30 mg) 
of microparticles was added to 900 ml distilled 
water as dissolution medium at 37 ºC and 
stirred at 50 rpm. At time intervals, samples (5 
ml) were withdrawn, filtered and analyzed 
spectrophotometrically at 242 nm.  The 
release results (in triplicate) were expressed 
as a percentage.   
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Fourier-transform infrared (FTIR) spectra 
 
Individual microparticles were crushed with 
pestle in an agate mortar. The crushed 
material was mixed with potassium bromide at 
1:100 ratios and compressed to a 2mm semi-
transparent disk under for 2 min. The FTIR 
spectra over the wavelength range of 4000–
400 cm
-1
 were recorded using an FTIR 
spectrometer (Perkin Elmer Spectrum One, 
Germany). 
 
Differential scanning calorimetry 
 
Differential scanning calorimetric studies were 
conducted in a Perkin Elmer differential 
scanning calorimeter Pyris 6 using an 
accurate weighed of the sample (10 mg) in a 
loosely covered aluminum pan and heated 
from 50 to 250°C at 10°C/min rate with 1min 
hold at 80°C under N2 parches.  An empty 
loosely covered aluminum pan was used as 
the reference.  
 
Measurement of in vitro mucoadhesive 
properties  
 
Male Wistar rats, with a mean weight of 300 ± 
30 g were anesthetized and killed by 
barbiturate overdose. The small intestine was 
removed and prepared by the following 
procedure: Using a syringe filled with 
physiological saline (NS), it was washed for 
10 min at 5–10 ml/min rate and followed by a 
20 min wash at 20–30 ml/min rate.  At least 
500 ml of NS was used to clean the tissue 
sample and then used immediately in the 
test
10
. Briefly, known quantities (30mg) of 
chitosan microparticles were suspended in NS 
and filled into the small intestine (about 10 cm 
in length) and sealed by knotting it with a fibre.  
The filled tissue was immersed in NS and 
incubated at 37°C for 60 min. The 
microparticle suspension was then removed 
and the number of microparticles present in 
the suspension before and after the adhesion 
study was counted using the microscopic 
method previously described for particle size 
determination. The percentage of 
microparticles that adhered to the tissue was 
calculated from the difference in the counts. At 







Experimental results were expressed as mean 
± SD. Student’s t-test and one-way analysis of 
variance (ANOVA) were applied to check 
significant differences in drug release, 
mucoadhesive properties, and particle size 
determination for different formulations.  
Differences were considered to be statistically 




A ternary phase diagram for sodium alginate, 
chitosan and calcium chloride illustrating 
phase separation/coacervation by the addition 
of an incompatible polymer is shown in Figure 
1.  The optimum concentration range required 
for each compound to form microparticles was 
identified in the triangular diagram as shown 
in Figure 1. This region was chosen by 
comparison of microparticles in terms of 
particle size, shape, reproducibility, symmetry 
and absence of free prednisolone crystals. 
The diagram was then used to select the 
various ratios of the materials in the 
formulation. The effects of stirring rate and 
time, spray apparatus type, distance of spray 
gun from chitosan solution surface, and the 
preparation method (one- or two-step) were 
evaluated. The formulations evaluated were 





Table 1 shows the prednisolone content of 
each of the formulations and it indicates that 
there is no statistical difference (p>0.05) in 
prednisolone content (a measure of % 
entrapment) between the three formulations. 
Geometric mean diameter and geometric 
standard deviation for each formulation are 
also shown in Table 1.  Increase in the 
molecular weight of chitosan resulted in a 
decrease in the geometric mean diameter and  
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Figure 1: Phase diagram showing separation/coacervation of  sodium alginate, chitosan, and 
calcium chloride.  and  
 
 
Table 1:  Prednisolone content, geometric mean diameter and mucoadhesiveness of  










% Mucoadhesion ±SD 
F1 98.97± 0.971 165 1.63 66.09%± 2.63 
F2 95.92± 0.992 147 1.55 75.52%± 2.39 
F3 96.68± 0.395 140 1.47 77.54%± 4.53 
 
 
geometric standard deviation of the 
microparticles.   
 
In vitro prednisolone release 
 
The in vitro release data are illustrated in 
Figure 2. It shows that there is no significant 
difference (p>0.05) between chitosan. 
However, highest MW chitosan produced 
significantly slower release rate than the other 
chitosans (p<0.05). 
 
In general, the FTIR spectrum of blank 
chitosan-alginate particles showed a broad 
band around 3500-3100 cm
-1
, indicating 
enhanced hydrogen bonding compared to that 
of chitosan or sodium alginate alone 
13
. On the 
other hand, as shown in Figure 3, this peak is 
clearly stronger in high and medium MW 
chitosans than in low MW chitosan.  
Moreover, the N-H bending vibration of non-
acrylated 2-aminoglucose primary amines of 
chitosan (1570 cm
-1
) and asymmetric and 
symmetric –C-O stretching at 1407 cm
-1
 of 
sodium alginate disappeared, indicating that 
the (-NH3
+





. Absence of these 
bonds in the FTIR spectra of chitosan/sodium 
alginate microparticles indicated the formation 
of an electrostatic bond between them (Figure 
3). 
 
The DSC studies were also performed to 
investigate the chitosan-alginate electrostatic 
interaction. The analysis of the DSC 
thermogram for the chitosan-sodium alginate 
particles showed a pair of exothermic and 
endothermic peaks at 230 ºC and 239 ºC, 
respectively.  The peak at 230 ºC may be 
related to the breakdown of weak and 
unspecific electrostatic interactions. The DSC  
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Figure 2: The release profiles of prednisolone from microparticles prepared with sodium alginate 




Figure 3: FTIR spectra of chitosan-sodium alginate microparticles prepared with low, medium and high 
MW  chitosan 
 
 
endothermic peak around 239.8 ºC, which 
was absent from either the chitosan or 
alginate thermogram, could be ascribed to the 
formation of an ionic pair between the 








The adsorption of chitosan-sodium alginate 
microparticles on rat small intestine was 
tested by counting the number of the particles 
adsorbed to the tissue. The results, shown in 
Honary et al  
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Table 1, indicate strong interaction between 
chitosan microparticles and mucous 
glycoprotein and/or mucosal surfaces, and 
which, as reported earlier, was dependent 
upon the method of preparation
17




The results show that using high MW chitosan 
under fixed processing conditions produces 
smaller and more uniform microparticles and 
this may be attributed to the higher viscosity of 
the high MW chitosan solution. When the 
alginate solution is sprayed into the chitosan 
solution, the spreading properties of alginate 
droplets would decrease as chitosan solution 
viscosity increases so that the droplets have 
less freedom to manouvre and spread, thus 
resulting in the production of smaller and more 
uniform microparticles. 
 
Usually, smaller particles show a higher 
release rate, but the reverse is the case here 
in that although the high MW chitosan 
generated smaller microparticles than other 
chitosans, it however produced a slower 
release rate than the others. It has been 
stated earlier that low MW chitosan diffuses 
more rapidly into the alginate gel during the 
formation of chitosan alginate beads
1
. On the 
other hand, high MW chitosan binds rapidly to 
the alginate bead surface but shows a more 
limited diffusion into the gel network; 
maximum binding was attained at around 4th 
hour. Although the low MW chitosan showed 
slow binding rate initially, maximum binding 
occurred within 24 hours, which is probably 
the time required to diffuse maximally into the 
gel bead. The need for diffusion into the gel is 
probably the underlying reason for the time 
required for binding to take place; thus, lower 
diffusion rate requires more time to bind
1
. In 
our study, contact time was limited (3 hr) and 
so the low MW chitosan did not have enough 
time to complete diffusion and reach 
maximum binding, while high MW chitosan 
produced a stronger bond than others by 
binding on to the microparticle surface. It has 
been shown earlier
13,14
 that there are various 
interactions (hydrogen binding and 
electrostatic interaction) between chitosan and 
alginate. The FTIR spectra of chitosan-
alginate microparticles prepared with different 
MW chitosans containing prednisolone 
showed no difference in electrostatic 
interaction; however, high and medium MW 
chitosans demonstrated stronger hydrogen 
binding than low MW chitosan.  
 
Figure 4 shows that the intensity of the pair of 
exothermic and endothermic peaks at 230ºC 
and 239 ºC rose with increase in the MW of 
chitosans. As stated earlier, lack of sufficient 







Figure 4:  DSC thermograms for chitosan and 
sodium alginate microparticles containing low (f1), 
medium (f2), and high (f3) MW chitosan plus 
prednisolone.  prednisolone release rates of 
microparticles containing low and medium MW 
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the alginate gel could be the underlying cause 
of the weaker electrostatic bonding, compared 
to the high MW chitosan that could bind on the 
surface of microparticles in a shorter time. 
This is buttressed by the DSC results. The 
DSC thermograms show two other peaks: a 
wide endothermic peak that span from 80 ºC 
up to 120 ºC and an exothermic peak at 
146ºC.  The first one can be attributed to the 
loss of water from microparticles (both surface 
and crystallization water) while the exothermic 
process of the second peak may be attributed 
to the partial crystallization of prednisolone 





Electrostatic interaction apparently plays an 
important role in the mucoadhesion of 
microparticles to rat small intestine tissue. It 
has been shown previously that the amount of 
chitosan adsorbed on the tissue increased 
with decrease in cross-linking level
17
. Our 
results also indicate that the mucoadhesion 
property of the microparticles was dependent 
on the MW of chitosan and the microparticle 
size.  Table 2 shows that microparticles 
prepared from high MW chitosan were 
significantly (p< 0.05) more mucoadhesive 




This work has demonstrated that when 
prednisolone alginate/chitosan microparticles 
were prepared with chitosans of varying MW 
using a coacervation method, smaller and 
more uniform microparticles were produced by 
high MW chitosan. These smaller particles 
also demonstrated superior mucoadhesive 
properties and lower release rate than those 
containing lower MW chitosans. Thus, it is 
feasible to produce chitosan-alginate 
microparticles of prednisolone with suitable 
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